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Abstract: This study analysed dangerous driving behaviours in twenty young occasional cannabis
users through objective and self-reported data, studying the relationship between the two aspects.
Visual function was assessed in a baseline session and after smoking cannabis, as well as speed-related
behaviour in a driving simulator. The participants responded to questionnaires on sociodemographic
factors, their consumption profile, and the incidence of dangerous behaviours (Dula Dangerous
Driving Index; DDDI). After cannabis use, the results revealed a significant deterioration in visual
function. In terms of speed management, they showed significantly greater acceleration force in
the two different sections of the route, and they drove significantly faster. Our correlations indicate
that males and heavier users display more risky speed management. Likewise, the heavier cannabis
users admitted to increased dangerous driving behaviour, and an accident in the preceding year was
associated with a trend towards aggressive driving behaviour according to the DDDI questionnaire.
The findings of this study suggest that cannabis users adopt dangerous behaviours when driving,
despite the effect this drug has on certain important functions, such as vision. The results suggest a
need for awareness-raising and information campaigns.
Keywords: aggressive driving; risk; driving safety; cannabis; THC; DUIC; visual quality; visual
fitness-to-drive; DDDI
1. Introduction
Cannabis is the most widely consumed illicit drug in the world. According to the
2020 European Drug Report, it is the most widely used drug in Europe. Almost 8%
of European adults have consumed cannabis in the past year, as have 15% of young
adults (15–34 years) [1]. In Spain, data from the 2018 report of the National Institute of
Toxicology and Forensic Sciences (INTCF) indicates that illegal drugs and psychopharma-
cological drugs were present in more than 43% of drivers who died in traffic accidents,
with cannabis and cocaine being the most frequently detected illicit substances (60% and
51%, respectively).
Epidemiological studies have concluded that driving under the influence of cannabis,
whose main psychoactive component is THC (∆9–tetrahydrocannabinol), can almost dou-
ble the risk of an accident [2,3]. The same increment was estimated by a systematic review
and meta-analysis, which added the special implication of cannabis in fatal crashes [4].
Likewise, other studies have indicated an association between cannabis use and traffic
accidents [5], with this substance also increasing the probability of being at fault [6]. Past
research has shown that acute intoxication can affect the driving skills needed for safe
driving [7–9]. Hartman et al., demonstrated the effects on both longitudinal and lateral
control, including higher lane weaving, decreased speeds, and higher headway following
distances [10,11]. Likewise, one of our recent studies showed that occasional cannabis
users drive outside the lane limits for longer and have a higher SDLP (standard deviation
of lateral position) under acute intoxication [12].
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The changes in driving performance reported in previous studies may be caused by
the alterations that cannabis compounds generate in key functions needed for driving.
It has been demonstrated that cannabis use affects aspects such as executive function
(time and tasks management) [13–15], attention capacity [16], and processing speed [14].
Moreover, cannabis also seems to alter the main sensorial mechanism involved in driving,
visual functioning [17]. It is estimated that vision constitutes the input channel for 90%
of the sensory information used while driving [18]. Several studies have demonstrated
slowed transmission of information through the visual path [19,20]. In functional terms,
cannabis seems to alter important visual parameters, including visual acuity, contrast sensi-
tivity, colour discrimination, ocular movements, and stereoscopic perception [12,17,21–25].
Previous evidence has shown that visually impaired drivers adopt some modifications
in their driving behaviour as a strategy to compensate for their decreased visual capac-
ity [26–28]. These modifications include avoiding driving on highways or reducing their
speeds [26–29]. Similarly, the visual changes caused by cannabis use could make drivers
feel less confident when driving, thus influencing their behaviour at the wheel.
Cannabis users also seem to have a tendency to exhibit risky behaviours. The study of
Vassallo et al., related driving under the influence of cannabis (DUIC) to speeding and other
dangerous on-road behaviours [30]. Richer and Bergeron used self-reported and objective
data, and found a link between DUIC and risky driving and negative emotional driv-
ing [31]. These authors observed a relationship between higher maximum speeds reached
on a simulator and greater incidence of self-reported dangerous behaviours. Similarly,
Bergeron and Paquette found that more frequent cannabis use and DUIC were associated
with higher maximum speeds [32]. However, these findings do not agree with other stud-
ies on driving simulators which reported a decrease in mean speed when driving after
cannabis use [8,10,33,34]. For other speed-related parameters, such as speed variability,
few simulator-based studies have found changes after cannabis use [8,11,33,34].
The aim of this study is, therefore, to analyse the effect that smoking cannabis has
on different driving performance parameters related to risk-taking behaviours (speed
management variables), as well as on one of the key aspects for safe driving, visual function.
Finally, we consider it interesting to analyse the relationship between objective driving
performance data, visual effects after smoking cannabis, demographics, and self-reported
data (i.e., consumption profile and self-reported dangerous behaviours when driving).
2. Materials and Methods
2.1. Participants
The study included 20 volunteers (mean age 23.3 ± 4.4 years; range 19–36 years; five
females), all of whom were occasional cannabis users, defined as self-reported cannabis
consumption of ≥1 but <4 times/week over the past three months [10,11]. Participants
indicated a similar frequency of use since they were consumers, avoiding including those
with more intense use in the past. They also had to meet other inclusion criteria, such as
being licensed drivers with at least one year’s experience, a driving frequency of at least
once a week, at least 6/6 (Snellen notation) monocular visual acuity with their habitual
correction worn for driving, and no binocular vision problems.
To identify possible alcohol or cannabis use disorders, we employed the Alcohol Disor-
ders Identification Test (AUDIT; cut-off score > 12 for women and >1 4 for men) [35] and the
Cannabis Use Disorders Identification Test-Revised (CUDIT-R; cut-off score > 12 points) [36].
If the volunteers exhibited a use disorder for either of these substances they were excluded,
as well as if they used other drugs, were pregnant or breastfeeding in the case of females,
and if they suffered simulator sickness.
This study was in line with the Declaration of Helsinki and was prospectively approved
by the University of Granada Human Research Ethics Committee (921/CCEIH/2019). Before
the testing sessions, the volunteers were interviewed and informed of the procedures,
details and possible consequences of this study, and they gave their informed consent.
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2.2. Visual Function
Visual function was evaluated binocularly (the normal state for driving) with the
habitual optical correction employed for driving (if any). For this purpose, we applied three
visual tests: visual acuity, contrast sensitivity, and stereoacuity. The first two parameters
and stereoacuity for far distance were evaluated using the charts available in the POLA
VistaVision Visual Chart System (DMD Med Tech srl. Torino, Italy). Visual acuity, or the
capacity to resolve high-contrast stimuli in detail, is the standardised test employed by the
licensing authorities [37]. It was measured at 5.5 m and the results were expressed on a
logMAR scale. Contrast sensitivity refers to the capacity of the visual system to distinguish
not only size, but also contrast. Although this visual function is not commonly included in
drivers’ visual exams [37], its importance has been highlighted by the literature on vision
and driving [38–40]. We obtained the minimum contrast required to see a visual grating
target over a uniform background, termed the contrast threshold. Contrast sensitivity is
the inverse of the contrast threshold for a given spatial frequency. The spatial frequencies
tested were 0.75, 1.5, 3, 6, 12 and 18 cycles per degree (cpd). Each of these had 8 contrast
levels and were evaluated at the recommended distance of 2.5 m.
Stereoacuity refers to three-dimensional vision and is defined as the capacity to
distinguish the spatial location of objects in the environment. This visual function is
non-standardised [37] in drivers’ visual exams, despite the importance of accurate spatial
orientation and localisation when driving. For far-vision (5.5 m), we employed the chart
in the system mentioned above. The stereotest can measure disparities ranging from 300
to 10 arcsecs using rows of five polarised vertical lines at each level of disparity assessed.
For near-vision testing, we employed the Fly Stereo Acuity Test with LEA Symbols (Stereo
Optical Co., Inc., Chicago, IL, USA). This is a polarised-based test that contains a graded
circle test, assessing disparities from 400 to 20 arcsecs. Stereoacuity was assessed while the
subjects were wearing polarised glasses.
2.3. Driving Simulator
The study employed the SIMAX DRIVING SIMULATOR v.4.0.8 BETA (SimaxVirt S.L.,
Pamplona, Spain). This driving simulator, successfully used in previous studies [41–43],
is fixed-based and provides a 180◦ field of view. The route comprised two main sections
(dual-carriageway and mountain road) which totalled 10.5 km. A full description of the
route sections is included in Table 1. The driving scenario was performed in daylight
and under good weather conditions, as can be seen in Figure 1, which shows screenshots
pertaining to the sections of the route.
To objectively assess dangerous/risky driving behaviours in the simulator, we con-
sidered several variables related to speed management for each section: the maximum
acceleration force and the maximum braking force (ranging between 0 and 1, where 0
is no pressure and 1 is the maximum pressure), the maximum speed reached along the
route (km/h), and the speed adaptation (i.e., speed—speed limit, so that negatives values
indicate driving under the speed limit) (km/h).
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Figure 1. Screenshots of the main sections driven along the route: dual carriageway (two top im-
ages), and mountain road (two bottom images). 
To objectively assess dangerous/risky driving behaviours in the simulator, we con-
sidered several variables related to speed management for each section: the maximum 
acceleration force and the maximum braking force (ranging between 0 and 1, where 0 is 
no pressure and 1 is the maximum pressure), the maximum speed reached along the route 
(km/h), and the speed adaptation (i.e., speed—speed limit, so that negatives values indi-
cate driving under the speed limit) (km/h).  
2.4. Self-Reported Data: Demographics and DDDI Questionnaire 
As part of the experiment, the participants completed several questionnaires. All of 
them were administered at the initial visit, ensuring that participants were not under the 
influence of cannabis or alcohol. Instructions for completion were administered verbally 
and were also written on each questionnaire. Subjects were instructed to respond based 
on their experience and took as much time as they needed. A member of the research team 
accompanied them and resolved any doubts about the content or meaning that arose. Par-
ticipants completed the first questionnaire on socio-demographic characteristics including 
age, sex and driving experience. Furthermore, they completed another questionnaire on 
their cannabis and alcohol use, the frequency of driving under the influence of the two 
drugs, and self-perceived risk during DUIC. This questionnaire comprised 24 items based 
on a questionnaire from a previous study [44]. 
The Dula Dangerous Driving Index (DDDI) was employed to characterise aggressive 
behaviour among the participants [45]. It has been shown that this index can be used as a 
composite measure for dangerous driving, being valid for clinical use [46]. This is a 28-
item questionnaire, where participants rate the frequency with which they exhibit certain 
behaviour, using a 5-point Likert scale ranging from 1 (never) to 5 (always). The total score 
can therefore range from 28 to 140. This questionnaire is comprised of three subscales: 
“risky driving” (RD, 12 items); negative cognitive/emotional driving (NCED, nine items); 
Figure 1. Screenshots of the main sections driven along the route: dual carriageway (two top images), and mountain road
(two bottom images).
2.4. Self-Reported Data: Demographics and DDDI Questionnaire
As part of the experiment, the particip nts completed several questionnaires. All of
them were administered at the initial visit, ensu ing t at participants were not under the
influence of cannabis or alcohol. Instructions for completion were administered verbally
and were also written on each questionnaire. Subjects were instructed to respond based on
their experience and took as much time as they needed. A member of the research team
accompanied them and resolved any doubts about the content or meaning that arose. Par-
ticipants completed the first questionnaire on socio-demographic characteristics including
age, sex and driving experience. Furthermore, they completed another questionnaire on
their cannabis and alcohol use, the frequency of driving under the influence of the two
drugs, and self-perceived risk during DUIC. This questionnaire comprised 24 items based
on a questionnaire from a previous study [44].
The Dula Dangerous Driving Index (DDDI) was employed to characterise aggressive
behaviour among the participants [45]. It has been shown that this index can be used
as a composite mea ure for dangerous driving, being valid for clinical use [46]. This is
a 28-item questionnaire, where participants rate the frequency with which they exhibit
certain behaviour, using a 5-point Likert scale ranging from 1 (never) to 5 (always). The
total score can therefore range from 28 to 140. This questionnaire is comprised of three
subscales: “risky driving” (RD, 12 items); negative cognitive/emotional driving (NCED,
nine items); and “aggressive driving” (AD, seven items). The mean score and total score
were btained for each subscale as well as the total DDDI score, by summing either the
score for each item in the subscale or th whole questi nnai e, respectively.
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2.5. Procedure
Once the participants had been informed about the study and had given their informed
consent, they underwent two training sessions with the driving simulator in order to
familiarise them with the system. The training sessions lasted about 15 min and involved a
similar scenario to those used in the experimental drives, but with no traffic or pedestrians.
Participants took a washout period of one week between training sessions, in order to
avoid any possible learning effects. If any symptoms of simulator sickness were noted, the
session was interrupted and the participant was excluded from the study.
When the training sessions had been completed, the two experimental sessions (one
involving no substance use and another after smoking a cannabis cigarette) were conducted
in a random order and at least one week apart. Each participant prepared the cannabis
cigarette in the way they usually do for their habitual consumption, given that our aim
was to simulate real use. They smoked the cigarette in about 10 min, with no particular
procedure being imposed, thus simulating their normal consumption behaviour. In each
session, which lasted approximately 75 min, the participants did the visual tests and
drove the route in the simulator, also in a random order. This duration guarantees a
considerable psychoactive effect during the session, given that this effect tapers off within
2–3 h [47]. As a safety precaution, the participants committed to not driving to and from
the laboratory. Moreover, they were all asked to abstain from alcohol for the 24 h prior to
each testing session and from cannabis use for four days. To obtain an objective drug-intake
screening during the sessions, a saliva drug test (Dräger DrugTest 5000, Dräger Safety AG
& Co. KGaA. Lübeck, Germany) was performed, which detects cannabis, amphetamines,
benzodiazepines, cocaine, methamphetamines, opiates, methadone, and ketamine. This
drug test has been proposed as a sensitive and valid method for detecting cannabinoids in
oral fluid [48,49]. For alcohol screening, we measured breath alcohol content (BrAC) with a
Dräger Alcotest 7110 MK-III.
2.6. Data Analysis
All the statistical procedures were performed using SPSS 26.0 software (SPSS Inc.,
Chicago, IL, USA). Descriptive statistics, including means and standard deviations (SDs)
were obtained for sociodemographic, vision, and driving variables. The frequency dis-
tribution was also included to describe the results from the self-reported questionnaires.
Comparisons between testing conditions (baseline and after smoking cannabis) were
made through the paired t-test and Wilcoxon test, depending on the data distribution
(Kolmogorov-Smirnov test).
To obtain a general score index quantifying the overall change experienced in visual
function after cannabis use, we calculated the Overall Visual Change Index. For each visual
parameter, we found the change after cannabis use (i.e., the value from the baseline session
minus the value after smoking cannabis). Then, z-scores for the change in each parameter
were computed, transforming the variables wherever necessary so that a negative value
indicated greater deterioration than the mean. Then, a mean z-score considering all visual
parameters was obtained, the value of which constituted the Overall Visual Change Index.
As an objective quantification of the driving style, we also computed the Speeding
Index. This index was obtained as in previous works for computing overall driving perfor-
mance scores [12,43,50], by calculating the z-scores for each driving variable and averaging
these to obtain a general index for each participant. On this occasion, a positive value for
all of them indicated a more aggressive driving style or greater risk while driving. The
Speeding Index was calculated for both sessions (baseline and after smoking cannabis),
and the two conditions were also averaged to provide a general Speeding Index that could
be used to correlate with other variables.
Both indexes were employed to assess the relationship between self-reported data,
driving behaviour, and visual changes after smoking cannabis. In this way, we computed a
correlation analysis (Spearman correlations) to investigate whether personal characteristics,
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driving style, or use profile could be associated with aggressive behaviour or an increased
risk of driving under the influence of cannabis.
3. Results
All the participants stated that they drive at least once per week, with a mean of
4.5 ± 2.3 days per week. Their self-reported mean driving experience was 4.1 ± 4.0 years
(range 1–17 years). The participants’ mean age when they first used cannabis was
17.6 ± 1.8 years. For the last six months, their self-reported cannabis-use frequency was:
30% 2–3 days/week; 10% once a week; 10% twice a month; 30% once a month; and 20%
less frequently. The AUDIT questionnaire score was 7.1 ± 3.8 (max. score 40 points), and
6.1 ± 4.1 for the CUDIT-R (max. score 32 points). Finally, when subjects were asked if they
felt their driving could be impaired after smoking cannabis, the response frequencies were:
5% “does not get worse”, 65% “gets slightly worse”, and 30% “gets much worse”.
3.1. Visual Assessment
After smoking cannabis, the participants demonstrated a significant deterioration in
visual function. Visual acuity demonstrated an average difference of 0.05 ± 0.05 logMAR
units, being significantly worse after cannabis use (t = −4.516; p < 0.001) (Figure 2). Contrast
sensitivity also worsened, with a mean reduction between conditions of 11.92 ± 16.54
(t = 3.223; p = 0.004) (Figure 2). Finally, stereoacuity was also altered, increasing an average
of 111.05 ± 88.12 arcsecs for the farthest distance evaluated (5.5 m) (Z = −3.623; p < 0.001)
and 10.50 ± 26.92 for the nearest distance (Z = −2.496; p = 0.013) (Figure 3).
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3.2. Risky Driving: Speed Management
Table 2 summarises the results of the variables analysed from the driving simulator
with regard to the speed management. As can be seen, we found a significantly higher
maximum acceleration force after smoking cannabis than in the baseline session, both on
the dual carriageway and the mountain road. The maximum speed was higher than the
speed limit for both conditions and on both sections of the route. However, average speed
adaptation indicated that, most of the time and along the entire route, the participants drove
under the speed limit (negative value), both in the baseline session and after smoking
cannabis. Nevertheless, the participants drove faster after smoking cannabis than in
the baseline session, with this difference being statistically significant for the mountain
road section.
Table 2. Comparison of speed management variables in the baseline session and after smoking cannabis. Mean, SD, and the










Max acceleration force * 0.72 (0.62–1.00) 0.89 (0.71–1.00) −2.179 0.029
Max braking force * 0.17 (0–0.41) 0.02 (0–0.75) −0.974 0.330
Max speed (km/h) * 130.52 (126.10–138.36) 130.69 (127.26–138.40) −0.597 0.550
Speed adaptation (km/h) −4.13 (6.60) −1.73 (10.98) −1.235 0.232
Mountain Road
Max acceleration force * 0.96 (0.80–1.00) 1.00 (1.00–1.00) −2.314 0.021
Max braking force * 1.00 (1.00–1.00) 1.00 (1.00–1.00) −1.000 0.317
Max speed (km/h) 105.58 (8.15) 103.20 (6.62) 1.123 0.275
Speed adaptation (km/h) −17.20 (2.15) −15.91 (1.95) −2.142 0.045
Total circuit Speeding Index −0.18 (0.40) 0.11 (0.43) −2.831 0.011
* Median (IQR) and Wilcoxon Test results are shown.
3.3. Driving under the Influence of Cannabis (DUIC): Self-Perceived Risk and Behaviour
3.3.1. General Profile of Use and Perception of Risk in Driving
All the participants were given the questionnaire used by Sexton et al., relating to their
cannabis and alcohol use profile (as these are often related) [44]. All of them indicated that
they smoked this substance in the company of other people (“social smokers”), while 5%
also smoked alone. Three participants (15%) indicated that they had had a car accident in
the preceding year, none of which involved injury to people. With regard to driving under
the influence of alcohol, more than half of the participants (65%) indicated that they had
done so when they were slightly intoxicated (after drinking less than four units of alcohol):
15% weekly; 30% monthly; 5% 2–10 times a year; 5% once a year; 10% once in their life.
Surprisingly, a huge proportion of them (52.8%) had also done so after a higher alcohol
intake (more than four alcohol units): 5.3% weekly; 21.1% 2–10 times a year; 5.3% once a
year; 21.1% once in their life. For cannabis, the results were similar, 55% of the total sample
reported driving under the influence of cannabis: 5% weekly; 5% monthly; 25% 2–10 times
a year; 20% once in their life. Worryingly, 15% reported they had even smoked cannabis
while driving. As for the combination of alcohol and cannabis, 25% said they had driven
after using both substances: 5% weekly; 5% monthly; 5% once a year; 10% once in their
life. On these occasions, 100% of the participants reported consuming less than four units
of alcohol.
All the participants were of the opinion that consuming more than four units of alcohol
negatively affected their driving; 55% said that it “gets a little worse”, while 45% said that
it “gets a lot worse”. Despite this, 52.8% acknowledged driving under these circumstances.
For cannabis, the perception of risk is lower, with 5% saying their driving is “not worse
after using cannabis”, while 65% think it is “a little worse” and only 30% consider it to be “a
lot worse”. Furthermore, these last two groups believe that after consumption, their driving
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remains negatively affected for an average of 2 h. During cannabis intoxication, they claim
to experience slower reaction speeds (79%), concentration and attention problems (63.3%),
sleepiness (58.1%), fatigue (15.8%), vision problems (10.6%), sensitivity to light (5.3%),
colour vision problems (5.3%), poor coordination (5.3%), and aggressive behaviour (5.3%).
3.3.2. Dula Dangerous Driving Index
The item with the highest score in the DDDI questionnaire was “I consider the actions of
other drivers to be inappropriate or ‘stupid’” (2.85 ± 0.67), corresponding to the NCE (Negative
Cognitive/Emotional Driving) subscale. On the other hand, the item with the lowest score
corresponded to the RD (Risky Driving) subscale: “I ‘drag race’ other drivers at stop lights to
get out in front” (1.05 ± 0.22).
If we analyse by subscales, the most frequent negative feeling for the NCE was “I
consider the actions of other drivers to be inappropriate or ‘stupid’.” The least frequent item was
“Passengers in my car/truck tell me to calm down”. For the subscale Aggressive Driving (AD),
the most frequent behaviours were “I verbally insult drivers who annoy me” and “When I
get stuck in a traffic jam I get very irritated.” The lowest-scoring behaviour in this subscale
was “I deliberately use my car/truck to block drivers who tailgate me”. Finally, for the subscale
Risky Driving (RD), the most frequent behaviour was “I will weave in and out of slower traffic”
while the least frequent was “I will drive on the shoulder or median strip to get around a traffic
jam.” The mean score per subscale was highest for NCE (2.08 ± 0.59), followed by RD
(1.55 ± 0.66) and, finally, AD (1.42 ± 0.36). This indicates that there is a higher incidence
of negative thoughts or feelings while driving than actual risky or aggressive behaviour
(Table 3).
3.3.3. Correlations between Visual Outcomes, Speed Management, and Self-Reported Data
Table 4 shows the Spearman’s correlations obtained between all the aspects studied.
The results show that frequency of consumption was significantly associated with the
Speeding Index (ρ = 0.649; p = 0.003), indicating that heavier cannabis users engaged
more in dangerous behaviours in terms of speed management on the simulator. Gender
was significantly associated with driving speed, with men adopting riskier behaviour on
the simulator, and having higher Speeding Indexes (ρ = −0.502; p = 0.029). Frequency
of consumption was also associated with gender, being higher in men than in women
(ρ = −0.509; p = 0.022). Confirming this finding, being male was also significantly associated
with a higher score on the CUDIT-r test (ρ = −0.047; p = 0.048). In addition, those who
drive the most are those who show the highest frequency of driving under the influence of
cannabis (DUIC) (ρ = 0.481; p = 0.032).
It should be noted that a higher monthly consumption of cannabis significantly
correlated with higher total scores in the DDDI (ρ = 0.591; p = 0.006) and in particular, with
the Negative Cognitive/Emotional Driving subscale (ρ = 0.591; p = 0.006). In addition, a
higher score in the AUDIT test significantly correlated with a higher score on the Risky
Driving subscale (ρ = 0.670; p = 0.001), indicating that people who report more hazardous
alcohol use also adopt risky behaviour behind the wheel more often. Similarly, the CUDIT-
R score showed a significant correlation with the overall DDDI score (ρ = 0.674; p = 0.001),
indicating that subjects with a more hazardous cannabis use adopt a more dangerous
driving behaviour. Specifically, those with higher CUDIT-r scores, more frequently adopted
the dangerous behaviours encompassed within Negative Cognitive/Emotional Driving
(ρ = 0.524; p = 0.018) and Risky Driving, (ρ = 0.476; p = 0.034). Finally, it is important to
note that the number of self-reported accidents significantly correlated with the DDDI
Aggressive Driving subscale score (ρ = 0.469; p = 0.037), meaning this kind of driving
behaviour could be the most dangerous. Finally, it is important to note that the deterioration
in visual function after smoking cannabis was not associated with either the speed that
drivers adopted or the self-reported data.
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Table 3. Scores obtained in the Dula Dangerous Driving Index Questionnaire (DDDI). For each item, the percentages according to frequency and the average score (SD) are indicated. For
each subscale, the total average score ± SD is shown.
Dula Dangerous Driving Index (DDDI) 1 = Never 2 3 4 5 = Always Mean (SD)
NCE1 I drive when I am angry or upset. 30% 15% 20% 15% 20% 2.80 (1.54)
NCE2 I lose my temper when driving. 60% 35% 5% 0% 0% 1.45 (0.61)
NCE3 I consider the actions of other drivers to be inappropriate or “stupid”. 5% 15% 70% 10% 0% 2.85 (0.67)
AD4 I flash my headlights when I am annoyed by another driver. 85% 10% 0% 5% 0% 1.25 (0.72)
AD5 I make rude gestures (e.g., giving “the finger”; yelling curse words) toward drivers who annoy me. 75% 25% 0% 0% 0% 1.25 (0.44)
AD6 I verbally insult drivers who annoy me. 45% 30% 15% 5% 5% 1.95 (1.15)
AD7 I deliberately use my car/truck to block drivers who tailgate me. 80% 15% 5% 0% 0% 1.25 (0.55)
AD8 I would tailgate a driver who annoys me. 95% 0% 5% 0% 0% 1.10 (0.45)
RD9 I “drag race” other drivers at stop lights to get out in front. 95% 5% 0% 0% 0% 1.05 (0.22)
RD10 I will illegally pass a car/truck that is going too slowly. 30% 45% 25% 0% 0% 1.95 (0.76)
AD11 I feel it is my right to strike back in some way, if I feel another driver has been aggressive toward me. 30% 50% 15% 5% 0% 1.95 (0.83)
NCE12 When I get stuck in a traffic jam, I get very irritated. 45% 35% 10% 10% 0% 1.85 (0.99)
RD13 I will race a slow-moving train to a railroad crossing. 95% 0% 5% 0% 0% 1.10 (0.45)
RD14 I will weave in and out of slower traffic. 25% 40% 20% 10% 5% 2.30 (1.13)
RD15 I will drive if I am only mildly intoxicated or buzzed. 45% 35% 20% 0% 0% 1.75 (0.79)
AD16 When someone cuts me off, I feel I should punish him/her. 90% 0% 10% 0% 0% 1.20 (0.62)
NCE17 I get impatient and/or upset when I fall behind schedule when I am driving. 10% 45% 35% 5% 5% 2.50 (0.95)
NCE18 Passengers in my car/truck tell me to calm down. 80% 20% 0% 0% 0% 1.20 (0.41)
NCE19 I get irritated when a car/truck in front of me slows down for no reason. 15% 45% 25% 10% 5% 2.45 (1.10)
RD20 I will cross double yellow lines to see if I can pass a slow-moving car/truck. 50% 40% 10% 0% 0% 1.60 (0.68)
RD21 I feel it is my right to get where I need to go as quickly as possible. 65% 25% 10% 0% 0% 1.45 (0.69)
NCE22 I feel that passive drivers should learn how to drive or stay home. 45% 40% 5% 5% 5% 1.85 (1.01)
RD23 I will drive on the shoulder or median strip to get around a traffic jam. 100% 0% 0% 0% 0% 1.00 (0.00)
RD24 When passing a car/truck on a 2-lane road, I will barely miss on-coming cars. 70% 20% 10% 0% 0% 1.40 (0.68)
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Table 3. Cont.
Dula Dangerous Driving Index (DDDI) 1 = Never 2 3 4 5 = Always Mean (SD)
RD25 I will drive when I am drunk. 70% 25% 0% 5% 0% 1.40 (0.75)
NCE26 I feel that I may lose my temper if I have to confront another driver. 45% 40% 10% 5% 0% 1.75 (0.85)
RD27 I consider myself to be a risk-taker. 40% 25% 25% 5% 5% 2.10 (1.17)
RD28 I feel that most traffic “laws” could be considered suggestions. 50% 45% 5% 0% 0% 1.55 (0.61)
TOTAL SCORE 47.70 (10.04)
NCE SCORE (Negative Cognitive/Emotional Driving) 14.30 (3.92)
AD SCORE (Aggressive Driving) 9.95 (3.10)
RD SCORE (Risky Driving) 19.05 (3.53)
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Table 4. Spearman’s correlation coefficients found for self-reported data.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
1 Age -
2 Gender −0.113 -
3 Cannabis use (monthly) −0.214 −0.509 * -
4 Years driving 0.909 ** −0.020 −0.242 -
5 Driving frequency (monthly) −0.188 0.138 0.029 −0.219 -
6 Frequencyof DUIC 0.052 −0.213 0.559 * 0.060 0.481 *
7 AUDIT −0.177 −0.071 0.332 −0.038 −0.459 * −0.250 -
8 CUDIT-R 0.054 −0.447 * 0.735 ** 0.001 −0.233 0.295 0.549 * -
9 Accidents (past year) 0.099 −0.243 0.101 0.122 −0.219 −0.142 0.135 0.012 -
10 DDDI score −0.074 −0.241 0.591 ** −0.063 −0.199 −0.024 0.553 * 0.674 ** 0.377 -
11 NCDE score −0.131 −0.344 0.591 ** −0.154 −0.313 −0.044 0.369 0.524 * 0.356 0.644 ** -
12 AD score −0.006 −0.031 0.278 0.107 0.024 −0.046 0.248 0.289 0.469 * 0.611 ** 0.293 -
13 RD score −0.127 −0.131 0.371 −0.009 −0.255 −0.097 0.670 ** 0.476 * 0.392 0.852 ** 0.415 0.540 * -
14 Overall Visual Change Index −0.077 −0.349 0.310 −0.081 0.085 −0.059 0.015 0.094 −0.313 −0.032 0.023 0.050 −0.164 -
15 Speeding Index 0.176 −0.502 * 0.649 ** 0.129 −0.148 0.138 0.171 0.366 0.026 0.112 0.141 −0.012 0.039 0.133 -
Notes: Gender: male = 1: female = 2; AUDIT = Alcohol Use Disorders Identification Test; CUDIT-R: Cannabis Use Disorders Identification Test Revised; DDDI = Dula Dangerous Driving Index; NCED = negative
cognitive/emotional driving; AD = aggressive driving; RD = risky driving. * p < 0.05; ** p < 0.01.
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4. Discussion
Visual performance deteriorated significantly after cannabis consumption. Visual
acuity, the visual function most widely employed to assess visual fitness-to-drive, was
significantly impaired under the influence of cannabis. These results are in line with
previous findings that suggest blurred vision in cannabis users [17,51]. In contrast to
this, previous studies have failed to find impaired static visual acuity after cannabis
use [52], although it has been found for dynamic visual acuity [53]. Contrast sensitivity,
a key visual function for driving performance according to the literature on vision and
driving [38,54], was also impaired. This result agrees with previous studies of acute
intoxication [12,17], and those evaluating permanent changes in cannabis users [24,25].
With regard to three-dimensional perception, it has been demonstrated that stereoacuity
is significantly impaired, meaning that drivers under the influence of cannabis could
have spatial orientation and localisation problems [12,17]. Moreover, this result is in line
with studies concluding that there is reduced occurrence of the binocular depth inversion
illusion [55,56]. This optical illusion appears to change the three-dimensional aspect of
an object if it is not congruent with the observer’s previous experience of that object [57].
Despite the significantly impaired visual function after smoking cannabis, the overall visual
change index did not correlate with speed management or self-reported data. This could
indicate that drivers are not sufficiently aware of the visual effects caused by cannabis use.
Our earlier research analysing the influence of this drug on a wide range of visual
parameters and its relationship with self-perceived effects, indicated that only contrast
sensitivity was significantly associated with the subjective perception of visual status
following cannabis use [17]. Our index included this visual parameter, in addition to
others, which could have resulted in the lack of a relationship with the driving data or
other factors. Moreover, although cannabis users may perceive some visual effects, it is
possible that the perceived change in visual quality is not enough to trigger a sense of risk
that would activate a series of strategies to promote safety.
Thus, while we expected that drivers under the influence of cannabis would adopt
a more cautious driving style due to the negative effect found on visual performance, an
essential sensory mechanism for driving, we actually found a contrary tendency. Both on
the dual carriageway and the mountain road, drivers pressed the accelerator significantly
harder. On the mountain road, they also drove significantly faster than in the baseline
session with respect to the speed limit, although they did not exceed it. A similar tendency
was observed on the dual carriageway, but they drove nearer to the speed limit. On the dual
carriageway, we found greater variability between the participants’ behaviour with regard
to speed adaptation than on the mountain road, with some of them even driving above the
speed limit. This result could be due to the fact that drivers may feel the dual carriageway
is less dangerous/difficult than the mountain road. Nevertheless, the changes observed
suggest a more dangerous driving style when driving under the effects of cannabis. In
previous studies, the most widely analysed speed-related parameter is mean speed, and
findings show that, in general, this decreases after cannabis use [8]. For example, the study
by Hartman et al., carried out on 19 occasional cannabis users (using the same definition of
occasional use as in this study) reported that cannabis use was associated with a reduction
in mean speed and an increased tendency to drive below the speed limit in the driving
simulator [11]. Also, Brands et al. found a reduction in speed in a driving simulator after
cannabis use in 91 young occasional cannabis users [58]. Given this previous evidence
and our own results, it seems important to analyse other speed-management parameters.
However, other work does suggest a link between DUIC and higher maximum speeds,
more in line with our results [31,32]. The speed-related behaviour found in our study could
be caused by the over-confidence of our participants in their own capabilities when they are
under the effect of cannabis, something that could also be concluded from their responses
to the questionnaire. Our results reflect the fact that 65% of participants reported driving
after drinking small quantities of alcohol (less than four units), and 52.5% had driven
even after drinking heavily (more than four units). However, 100% of the participants
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thought that alcohol negatively affected their driving. Interestingly, the data reveals that
the perception of risk associated with cannabis use while driving is lower, as although 55%
of participants have driven after cannabis use, 5% think that their driving is not worse
after smoking cannabis and 65% think that it is only slightly worse. In Spain, the DUIC
percentage seems to be higher than in other countries, such as the United States or Canada,
although in the latter it has been found that it is more common among young people to
drive under the influence of cannabis than to drive after drinking alcohol [59,60].
The correlation analysis showed no relationship between the change in visual perfor-
mance and participant’s driving behaviour. Vision is unarguably essential for driving [38],
and previous research has demonstrated that visually impaired drivers adopt some strate-
gies when driving trying to compensate for such impairment. For example, older drivers
with cataract tend to avoid driving during rush hour, at night or in heavy traffic [27,28,61].
Likewise, these drivers tend to adopt lower speeds than older drivers without visual
impairment [29,50]. The impairment of visual function caused by cannabis use may be not
enough for the participants to perceive themselves as having visual difficulties, so it does
not bear an influence on their risk management while driving. On the contrary, some stud-
ies have found a link between DUIC and dangerous driving behaviour in everyday life [32].
In general, the average scores reported for each DDDI subscale in our study are lower than
those found by other authors [62,63]. This difference may be due to the personal traits of
the participants, for example, agreeableness, which has been found to negatively correlate
with the incidence of all types of dangerous behaviour [63]. Nonetheless, our correlation
analysis of self-reported data showed some interesting associations. As mentioned, our
results confirm heavier cannabis use in males [64], and being a male also correlated with a
greater incidence of speed-related dangerous behaviours (higher speeding indexes) [65,66].
Moreover, the correlations showed that people with increased alcohol and cannabis use
adopt a more dangerous driving style. Specifically, heavier cannabis users have higher
speeding indexes and more negative emotional behaviour, and heavier cannabis and alco-
hol users were more vulnerable to risky driving practices. These results agree with other
studies, also employing the DDDI [31,32], showing that DUIC is associated with more risky
driving [60,67]. In the study by Bergeron and Paquette, the authors found no link between
increased risky behaviour and traffic accidents [32]. However, in our study, the Aggressive
Driving subscale score did correlate positively with the number of self-reported accidents
in the previous year. A recent study employing the DDDI concluded that negativity biases
could explain differences in dangerous driving and accident risk between drivers [68].
Our results also suggest that some dangerous behaviour is more closely linked to traffic
accidents than others.
Limitations of the Study
This study is not without limitations, and we must consider these when interpreting
the results. Firstly, the use of a driving simulator supposes an important limitation due to
its inability to completely represent the realism of the driving environment. The simulator
is designed to reproduce the characteristics of the different environments as accurately
as possible, but it cannot capture the dynamism of real-life driving. Nevertheless, this
simulator has been used successfully in previous studies [41,43] and there is evidence to
support the relative validity of driving simulators with respect to actual driving [69,70].
Simulators mean work can be conducted under safe conditions and in fully controlled situ-
ations, which would be impossible in real-world scenarios, and they are hugely important
in studies like this one for ethical reasons. However, it is known that driving simulators are
more sensitive to the effects of cannabis than on-road studies of driving performance [9,71],
so the results obtained in simulator-based studies should be interpreted with caution when
generalising them to a real situation.
Secondly, the fact that each participant consumed the THC cigarette as they usually do,
does not allow us to establish a relationship between dose and effect. We might think that
by not measuring blood concentration we are also unable to quantify the effect on vision
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and driving; however, the relationship between dose, blood concentration, and effect is
non-linear [47,72]. Our goal was to study the consequences that a participant’s typical use,
on a normal day, has on vision and driving, and thus be able to relate these two aspects from
a real perspective. These results should serve as a starting point for future work involving
varying doses, or different administration routes. Finally, it is important to consider that the
limited sample size prevents the generalization of these results. Furthermore, the age and
gender distribution does not represent the general population, as only young participants
and a higher proportion of males were included. Although a lower incidence of cannabis-
impaired driving has been demonstrated in older and female users [73–75], they might
show different behaviours, so this issue should be considered in future studies. Therefore,
further research with larger samples, different ages and similar gender distribution is
needed to confirm the findings of this study.
5. Conclusions
Cannabis is one of the most commonly detected illicit drugs among drivers. This
drug causes physical or cognitive alterations in functions needed for safe driving. In
addition, previous research has demonstrated that cannabis users may be more prone to
some dangerous driving behaviours. In this study, we analysed the effects of smoking
cannabis on visual function and on several driving performance parameters related to risky
behaviours. We also investigated dangerous driving behaviours using self-reported data.
Finally, the relationship between all these aspects was analysed.
Despite the fact that vision, a key sensorial mechanism for driving, was significantly
altered after cannabis consumption, the participants did not exhibit a more cautious
driving style under these circumstances. In fact, some of the variables studied in this work,
such as the acceleration pedal force and the speed relative to the speed limit, indicated a
riskier attitude under the effects of cannabis. These results seem to suggest that cognitive
changes due to cannabis use have a greater influence on driving behaviour than the
sensory changes found in visual function. Also, being male and a heavier cannabis user
correlated significantly with greater speeding indexes, suggesting a more dangerous or
riskier driving style.
On the other hand, although our sample has lower scores in the different subscales of
the Dula Dangerous Driving Index (DDDI), data on driver demographics and use profiles
have revealed significant associations between increased cannabis use and dangerous
driving behaviour. Moreover, our results suggest a lack of awareness of the risks associated
with cannabis use in driving, given that a considerable proportion of participants have
driven after smoking cannabis, and most think that it only slightly affects their ability
to drive.
There is, therefore, still a considerable need for awareness-raising and information
campaigns aimed at the general public, as well as for research that provides adequate
insights into how this drug affects both short- and long-term vision and the ability to
drive safely. Finally, testing positive for cannabis could alert the authorities about certain
behaviours that may compromise safe driving.
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